ID: ALA4582996

Max Phase: Preclinical

Molecular Formula: C26H24ClN3O3

Molecular Weight: 461.95

Molecule Type: Unknown

Associated Items:

Representations

Canonical SMILES:  COc1ccc(NC(=O)N2CCc3c([nH]c4ccc(Cl)cc34)C2c2ccc(OC)cc2)cc1

Standard InChI:  InChI=1S/C26H24ClN3O3/c1-32-19-8-3-16(4-9-19)25-24-21(22-15-17(27)5-12-23(22)29-24)13-14-30(25)26(31)28-18-6-10-20(33-2)11-7-18/h3-12,15,25,29H,13-14H2,1-2H3,(H,28,31)

Standard InChI Key:  MMZWBGOFUUIUSC-UHFFFAOYSA-N

Associated Targets(non-human)

Human gammaherpesvirus 4 1538 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 461.95Molecular Weight (Monoisotopic): 461.1506AlogP: 6.02#Rotatable Bonds: 4
Polar Surface Area: 66.59Molecular Species: NEUTRALHBA: 3HBD: 2
#RO5 Violations: 1HBA (Lipinski): 6HBD (Lipinski): 2#RO5 Violations (Lipinski): 1
CX Acidic pKa: 13.90CX Basic pKa: CX LogP: 5.18CX LogD: 5.18
Aromatic Rings: 4Heavy Atoms: 33QED Weighted: 0.39Np Likeness Score: -0.94

References

1. Tikhmyanova N, Paparoidamis N, Romero-Masters J, Feng X, Mohammed FS, Reddy PAN, Kenney SC, Lieberman PM, Salvino JM..  (2019)  Development of a novel inducer for EBV lytic therapy.,  29  (16): [PMID:31255485] [10.1016/j.bmcl.2019.06.034]

Source